Concepts (248)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Rectal Neoplasms | 21 | 2025 | 98 | 5.920 |
Why?
|
| Colectomy | 13 | 2021 | 104 | 3.800 |
Why?
|
| Rectum | 13 | 2023 | 86 | 3.020 |
Why?
|
| Colonic Diseases | 4 | 2020 | 33 | 2.260 |
Why?
|
| Patient Readmission | 6 | 2020 | 421 | 2.240 |
Why?
|
| Elective Surgical Procedures | 7 | 2021 | 112 | 2.230 |
Why?
|
| Digestive System Surgical Procedures | 10 | 2021 | 88 | 2.170 |
Why?
|
| Transanal Endoscopic Surgery | 7 | 2024 | 23 | 2.020 |
Why?
|
| Colorectal Surgery | 6 | 2025 | 53 | 1.960 |
Why?
|
| Postoperative Complications | 16 | 2024 | 1201 | 1.890 |
Why?
|
| Colon | 6 | 2021 | 136 | 1.860 |
Why?
|
| Laparoscopy | 9 | 2023 | 427 | 1.800 |
Why?
|
| Rectal Diseases | 3 | 2020 | 27 | 1.750 |
Why?
|
| Colorectal Neoplasms | 7 | 2023 | 263 | 1.720 |
Why?
|
| Analgesics, Opioid | 3 | 2021 | 488 | 1.530 |
Why?
|
| Colonic Neoplasms | 5 | 2023 | 215 | 1.460 |
Why?
|
| Crohn Disease | 5 | 2021 | 106 | 1.320 |
Why?
|
| Diverticulitis | 3 | 2020 | 28 | 1.210 |
Why?
|
| Surgeons | 5 | 2022 | 161 | 1.110 |
Why?
|
| Length of Stay | 8 | 2021 | 779 | 0.990 |
Why?
|
| Retrospective Studies | 22 | 2024 | 6085 | 0.990 |
Why?
|
| Pain, Postoperative | 3 | 2021 | 141 | 0.990 |
Why?
|
| Humans | 67 | 2025 | 59476 | 0.960 |
Why?
|
| Middle Aged | 30 | 2024 | 16339 | 0.950 |
Why?
|
| Risk Assessment | 4 | 2020 | 1927 | 0.950 |
Why?
|
| Constipation | 1 | 2024 | 14 | 0.920 |
Why?
|
| Diverticulitis, Colonic | 4 | 2020 | 32 | 0.890 |
Why?
|
| Patient Discharge | 4 | 2021 | 492 | 0.880 |
Why?
|
| Male | 38 | 2025 | 27794 | 0.860 |
Why?
|
| Healthcare Disparities | 3 | 2023 | 330 | 0.850 |
Why?
|
| Quality Improvement | 6 | 2019 | 418 | 0.810 |
Why?
|
| Adenocarcinoma | 5 | 2019 | 323 | 0.810 |
Why?
|
| Female | 36 | 2025 | 30779 | 0.790 |
Why?
|
| Sarcopenia | 1 | 2022 | 18 | 0.760 |
Why?
|
| Colonic Pseudo-Obstruction | 1 | 2021 | 1 | 0.760 |
Why?
|
| Cecal Diseases | 1 | 2021 | 3 | 0.760 |
Why?
|
| Intestinal Volvulus | 1 | 2021 | 4 | 0.750 |
Why?
|
| Sigmoid Diseases | 1 | 2021 | 5 | 0.750 |
Why?
|
| Surgical Wound Infection | 2 | 2014 | 110 | 0.750 |
Why?
|
| Rectal Prolapse | 2 | 2019 | 11 | 0.740 |
Why?
|
| Oxycodone | 1 | 2021 | 30 | 0.740 |
Why?
|
| Fecal Incontinence | 2 | 2024 | 28 | 0.710 |
Why?
|
| Home Care Services | 2 | 2020 | 97 | 0.680 |
Why?
|
| Inappropriate Prescribing | 1 | 2021 | 64 | 0.670 |
Why?
|
| Aged | 20 | 2024 | 13423 | 0.670 |
Why?
|
| Drug Prescriptions | 1 | 2021 | 168 | 0.670 |
Why?
|
| Colonic Pouches | 1 | 2019 | 16 | 0.660 |
Why?
|
| Proctocolectomy, Restorative | 1 | 2019 | 18 | 0.660 |
Why?
|
| Skilled Nursing Facilities | 1 | 2020 | 83 | 0.650 |
Why?
|
| Preoperative Care | 2 | 2020 | 180 | 0.640 |
Why?
|
| Drug Utilization | 1 | 2021 | 208 | 0.640 |
Why?
|
| Anastomosis, Surgical | 5 | 2023 | 107 | 0.640 |
Why?
|
| Practice Patterns, Physicians' | 3 | 2021 | 693 | 0.640 |
Why?
|
| Minimally Invasive Surgical Procedures | 2 | 2016 | 98 | 0.630 |
Why?
|
| Gastrointestinal Stromal Tumors | 1 | 2019 | 19 | 0.630 |
Why?
|
| Insurance Coverage | 2 | 2016 | 99 | 0.620 |
Why?
|
| Colitis, Ulcerative | 1 | 2019 | 71 | 0.620 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2019 | 31 | 0.620 |
Why?
|
| Treatment Outcome | 15 | 2024 | 5293 | 0.600 |
Why?
|
| Neoplasm Staging | 6 | 2023 | 448 | 0.590 |
Why?
|
| Enterocolitis, Pseudomembranous | 2 | 2015 | 33 | 0.570 |
Why?
|
| Adult | 17 | 2025 | 15704 | 0.560 |
Why?
|
| Colon, Transverse | 1 | 2017 | 4 | 0.550 |
Why?
|
| Hospital Costs | 2 | 2014 | 119 | 0.540 |
Why?
|
| Postoperative Care | 1 | 2017 | 115 | 0.540 |
Why?
|
| Colostomy | 2 | 2023 | 23 | 0.540 |
Why?
|
| United States | 14 | 2025 | 7431 | 0.530 |
Why?
|
| Inflammatory Bowel Diseases | 3 | 2020 | 95 | 0.500 |
Why?
|
| Risk Factors | 12 | 2020 | 4991 | 0.500 |
Why?
|
| Hospitals | 1 | 2018 | 378 | 0.490 |
Why?
|
| Patient Safety | 1 | 2017 | 238 | 0.470 |
Why?
|
| Robotic Surgical Procedures | 1 | 2017 | 115 | 0.460 |
Why?
|
| Intestinal Diseases | 1 | 2014 | 33 | 0.450 |
Why?
|
| Margins of Excision | 4 | 2024 | 24 | 0.450 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2024 | 300 | 0.420 |
Why?
|
| Anastomotic Leak | 3 | 2021 | 33 | 0.370 |
Why?
|
| Cohort Studies | 5 | 2022 | 2377 | 0.350 |
Why?
|
| Health Status Disparities | 1 | 2011 | 137 | 0.340 |
Why?
|
| Quality of Life | 5 | 2024 | 1138 | 0.340 |
Why?
|
| Internship and Residency | 3 | 2025 | 748 | 0.330 |
Why?
|
| Intestinal Obstruction | 2 | 2023 | 49 | 0.330 |
Why?
|
| Hospital Mortality | 4 | 2017 | 845 | 0.320 |
Why?
|
| Morbidity | 4 | 2021 | 113 | 0.320 |
Why?
|
| Follow-Up Studies | 5 | 2021 | 2341 | 0.310 |
Why?
|
| Practice Guidelines as Topic | 3 | 2021 | 706 | 0.300 |
Why?
|
| Time Factors | 6 | 2019 | 3619 | 0.280 |
Why?
|
| Aged, 80 and over | 5 | 2021 | 5125 | 0.270 |
Why?
|
| Reoperation | 2 | 2021 | 273 | 0.270 |
Why?
|
| Societies, Medical | 3 | 2024 | 338 | 0.260 |
Why?
|
| Colonoscopy | 4 | 2020 | 86 | 0.250 |
Why?
|
| Intensive Care Units | 2 | 2020 | 430 | 0.230 |
Why?
|
| Odds Ratio | 2 | 2020 | 748 | 0.230 |
Why?
|
| Academic Medical Centers | 2 | 2017 | 309 | 0.230 |
Why?
|
| Perineum | 2 | 2021 | 18 | 0.230 |
Why?
|
| Mesocolon | 1 | 2023 | 2 | 0.220 |
Why?
|
| Surgical Stomas | 1 | 2023 | 8 | 0.210 |
Why?
|
| Anus Neoplasms | 1 | 2022 | 23 | 0.200 |
Why?
|
| Consumer Health Information | 1 | 2022 | 36 | 0.200 |
Why?
|
| Comorbidity | 2 | 2017 | 1080 | 0.200 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2023 | 396 | 0.200 |
Why?
|
| Critical Care | 2 | 2016 | 399 | 0.190 |
Why?
|
| Digestive System Fistula | 1 | 2021 | 3 | 0.190 |
Why?
|
| Neostigmine | 1 | 2021 | 3 | 0.190 |
Why?
|
| Proportional Hazards Models | 1 | 2023 | 674 | 0.190 |
Why?
|
| Medical Chaperones | 1 | 2021 | 3 | 0.190 |
Why?
|
| Organizational Policy | 1 | 2021 | 47 | 0.190 |
Why?
|
| Chronic Disease | 1 | 2024 | 717 | 0.180 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2021 | 45 | 0.180 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2021 | 69 | 0.180 |
Why?
|
| Decompression, Surgical | 1 | 2021 | 61 | 0.180 |
Why?
|
| Pelvis | 1 | 2021 | 57 | 0.180 |
Why?
|
| Ileostomy | 4 | 2023 | 25 | 0.180 |
Why?
|
| Patient Selection | 3 | 2018 | 466 | 0.170 |
Why?
|
| Clinical Competence | 1 | 2025 | 683 | 0.170 |
Why?
|
| Constriction, Pathologic | 2 | 2021 | 112 | 0.170 |
Why?
|
| Online Systems | 1 | 2020 | 19 | 0.170 |
Why?
|
| Severity of Illness Index | 2 | 2015 | 1483 | 0.170 |
Why?
|
| Appendiceal Neoplasms | 1 | 2019 | 8 | 0.170 |
Why?
|
| Multivariate Analysis | 2 | 2021 | 903 | 0.160 |
Why?
|
| Clinical Protocols | 1 | 2020 | 136 | 0.160 |
Why?
|
| Ischemia | 1 | 2021 | 199 | 0.160 |
Why?
|
| Acute Disease | 1 | 2021 | 660 | 0.160 |
Why?
|
| Long-Term Care | 1 | 2020 | 177 | 0.160 |
Why?
|
| Prospective Studies | 5 | 2024 | 3072 | 0.160 |
Why?
|
| Surgical Procedures, Operative | 1 | 2020 | 137 | 0.160 |
Why?
|
| Delphi Technique | 1 | 2019 | 77 | 0.160 |
Why?
|
| Adolescent | 3 | 2022 | 5854 | 0.150 |
Why?
|
| Lymph Nodes | 1 | 2019 | 215 | 0.150 |
Why?
|
| Prognosis | 2 | 2014 | 1598 | 0.150 |
Why?
|
| Universities | 1 | 2019 | 144 | 0.150 |
Why?
|
| Education, Medical, Graduate | 2 | 2020 | 317 | 0.150 |
Why?
|
| Clinical Decision-Making | 1 | 2019 | 148 | 0.150 |
Why?
|
| Disease Management | 1 | 2020 | 220 | 0.150 |
Why?
|
| Inpatients | 1 | 2021 | 292 | 0.150 |
Why?
|
| Frailty | 1 | 2020 | 124 | 0.150 |
Why?
|
| Self Report | 1 | 2021 | 359 | 0.150 |
Why?
|
| Social Media | 1 | 2020 | 116 | 0.150 |
Why?
|
| General Surgery | 1 | 2020 | 191 | 0.140 |
Why?
|
| Telemedicine | 1 | 2022 | 310 | 0.140 |
Why?
|
| Survival Rate | 3 | 2018 | 801 | 0.140 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2020 | 678 | 0.130 |
Why?
|
| Diffusion of Innovation | 1 | 2017 | 55 | 0.130 |
Why?
|
| Intestine, Small | 1 | 2016 | 77 | 0.130 |
Why?
|
| Hospitals, High-Volume | 1 | 2016 | 32 | 0.120 |
Why?
|
| Checklist | 1 | 2016 | 72 | 0.120 |
Why?
|
| Total Quality Management | 1 | 2015 | 56 | 0.120 |
Why?
|
| Dextrans | 1 | 2015 | 45 | 0.120 |
Why?
|
| Electric Stimulation Therapy | 1 | 2015 | 27 | 0.120 |
Why?
|
| Quality of Health Care | 1 | 2019 | 514 | 0.120 |
Why?
|
| Databases, Factual | 2 | 2016 | 815 | 0.120 |
Why?
|
| Surveys and Questionnaires | 4 | 2025 | 2516 | 0.120 |
Why?
|
| Prostheses and Implants | 1 | 2015 | 66 | 0.120 |
Why?
|
| Physical Examination | 1 | 2015 | 104 | 0.120 |
Why?
|
| Intestines | 1 | 2016 | 158 | 0.120 |
Why?
|
| Efficiency, Organizational | 1 | 2015 | 93 | 0.120 |
Why?
|
| Chemoradiotherapy, Adjuvant | 1 | 2014 | 9 | 0.120 |
Why?
|
| Hyaluronic Acid | 1 | 2015 | 66 | 0.120 |
Why?
|
| Colonoscopes | 1 | 2014 | 3 | 0.120 |
Why?
|
| Lenses | 1 | 2014 | 8 | 0.120 |
Why?
|
| Surface Plasmon Resonance | 1 | 2014 | 33 | 0.110 |
Why?
|
| Terahertz Imaging | 1 | 2014 | 11 | 0.110 |
Why?
|
| Lasers | 1 | 2014 | 34 | 0.110 |
Why?
|
| Medical Errors | 1 | 2016 | 195 | 0.110 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2019 | 1515 | 0.110 |
Why?
|
| Anal Canal | 1 | 2014 | 34 | 0.110 |
Why?
|
| Costs and Cost Analysis | 1 | 2014 | 98 | 0.110 |
Why?
|
| Cost of Illness | 1 | 2014 | 156 | 0.110 |
Why?
|
| Predictive Value of Tests | 2 | 2020 | 1029 | 0.100 |
Why?
|
| Cost-Benefit Analysis | 1 | 2014 | 299 | 0.100 |
Why?
|
| Image Enhancement | 1 | 2014 | 188 | 0.100 |
Why?
|
| Diet | 1 | 2015 | 497 | 0.090 |
Why?
|
| Age Factors | 2 | 2020 | 1504 | 0.090 |
Why?
|
| Evidence-Based Medicine | 3 | 2019 | 443 | 0.090 |
Why?
|
| Colitis | 2 | 2015 | 74 | 0.090 |
Why?
|
| Massachusetts | 1 | 2016 | 2023 | 0.090 |
Why?
|
| Prevalence | 1 | 2014 | 1257 | 0.090 |
Why?
|
| Emergencies | 1 | 2010 | 110 | 0.080 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 409 | 0.080 |
Why?
|
| Logistic Models | 2 | 2010 | 1237 | 0.080 |
Why?
|
| Anti-Bacterial Agents | 1 | 2015 | 737 | 0.080 |
Why?
|
| Quality Assurance, Health Care | 1 | 2011 | 250 | 0.080 |
Why?
|
| Metabolomics | 1 | 2009 | 49 | 0.080 |
Why?
|
| Hospitalization | 1 | 2016 | 1293 | 0.080 |
Why?
|
| Operative Time | 2 | 2021 | 76 | 0.080 |
Why?
|
| Weight Loss | 1 | 2010 | 263 | 0.070 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2009 | 291 | 0.070 |
Why?
|
| Rectal Fistula | 1 | 2008 | 20 | 0.070 |
Why?
|
| Internet | 2 | 2022 | 449 | 0.070 |
Why?
|
| Young Adult | 2 | 2014 | 4277 | 0.070 |
Why?
|
| Feasibility Studies | 2 | 2021 | 526 | 0.070 |
Why?
|
| Early Detection of Cancer | 1 | 2009 | 267 | 0.060 |
Why?
|
| Patient Satisfaction | 2 | 2022 | 415 | 0.060 |
Why?
|
| Smoking | 1 | 2010 | 826 | 0.060 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 2024 | 21 | 0.060 |
Why?
|
| Reproducibility of Results | 2 | 2022 | 1561 | 0.060 |
Why?
|
| Cross-Sectional Studies | 2 | 2021 | 2383 | 0.060 |
Why?
|
| Network Meta-Analysis | 1 | 2023 | 12 | 0.050 |
Why?
|
| Search Engine | 1 | 2022 | 9 | 0.050 |
Why?
|
| Bayes Theorem | 1 | 2023 | 110 | 0.050 |
Why?
|
| Syndrome | 1 | 2022 | 172 | 0.050 |
Why?
|
| Personal Satisfaction | 1 | 2022 | 76 | 0.050 |
Why?
|
| Comprehension | 1 | 2022 | 131 | 0.050 |
Why?
|
| Neoadjuvant Therapy | 2 | 2014 | 71 | 0.050 |
Why?
|
| Aftercare | 1 | 2021 | 71 | 0.050 |
Why?
|
| Perioperative Period | 1 | 2021 | 19 | 0.050 |
Why?
|
| Attitude of Health Personnel | 1 | 2025 | 552 | 0.040 |
Why?
|
| Preoperative Period | 1 | 2020 | 61 | 0.040 |
Why?
|
| Treatment Failure | 1 | 2021 | 186 | 0.040 |
Why?
|
| Safety | 1 | 2021 | 141 | 0.040 |
Why?
|
| Outpatients | 1 | 2021 | 137 | 0.040 |
Why?
|
| Specialty Boards | 1 | 2020 | 13 | 0.040 |
Why?
|
| Accreditation | 1 | 2020 | 73 | 0.040 |
Why?
|
| Data Accuracy | 1 | 2020 | 28 | 0.040 |
Why?
|
| Terminology as Topic | 1 | 2021 | 133 | 0.040 |
Why?
|
| Stents | 1 | 2023 | 464 | 0.040 |
Why?
|
| Appointments and Schedules | 1 | 2019 | 55 | 0.040 |
Why?
|
| Pilot Projects | 2 | 2014 | 916 | 0.040 |
Why?
|
| Walking | 1 | 2020 | 228 | 0.040 |
Why?
|
| Needs Assessment | 1 | 2019 | 187 | 0.040 |
Why?
|
| Abdomen | 1 | 2018 | 91 | 0.040 |
Why?
|
| Diagnostic Imaging | 1 | 2020 | 245 | 0.040 |
Why?
|
| Biopsy | 2 | 2009 | 410 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2020 | 1286 | 0.030 |
Why?
|
| Decision Making | 1 | 2019 | 395 | 0.030 |
Why?
|
| Infant | 1 | 2020 | 1493 | 0.030 |
Why?
|
| Fecal Microbiota Transplantation | 1 | 2015 | 16 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2020 | 1796 | 0.030 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2015 | 32 | 0.030 |
Why?
|
| Program Development | 1 | 2015 | 203 | 0.030 |
Why?
|
| Defecation | 1 | 2014 | 14 | 0.030 |
Why?
|
| Equipment Failure Analysis | 1 | 2014 | 74 | 0.030 |
Why?
|
| Organ Sparing Treatments | 1 | 2014 | 15 | 0.030 |
Why?
|
| Bacterial Vaccines | 1 | 2015 | 87 | 0.030 |
Why?
|
| Infection Control | 1 | 2015 | 95 | 0.030 |
Why?
|
| Pelvic Floor | 1 | 2013 | 10 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2014 | 228 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2014 | 248 | 0.030 |
Why?
|
| Equipment Design | 1 | 2014 | 330 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2014 | 271 | 0.020 |
Why?
|
| Intestinal Mucosa | 1 | 2014 | 227 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2014 | 1097 | 0.020 |
Why?
|
| Emergency Treatment | 1 | 2011 | 52 | 0.020 |
Why?
|
| Child | 1 | 2020 | 4205 | 0.020 |
Why?
|
| Algorithms | 1 | 2013 | 979 | 0.020 |
Why?
|
| Urogenital Surgical Procedures | 1 | 2008 | 5 | 0.020 |
Why?
|
| Drainage | 1 | 2008 | 150 | 0.020 |
Why?
|
| Precancerous Conditions | 1 | 2006 | 70 | 0.020 |
Why?
|
| Incidence | 1 | 2006 | 1239 | 0.010 |
Why?
|